Adjustment of antisnake venom dose in snake bite poisoning
Not Applicable
- Conditions
- Health Condition 1: T630- Toxic effect of snake venom
- Registration Number
- CTRI/2024/05/067306
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients (aged =18 years) irrespective of
gender and admitted to the hospital with snake bite envenomation and on therapy with ASV.
Exclusion Criteria
1.Patients who were managed with supportive therapy alone 2. Patients referred from other centres with the history of snakebites with concomitant hospital acquired infections. 3.Patients with history of snakebite more than 10 days and referred for further management.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is the effectiveness of ASV treatment dosing in terms of recovery/mortality <br/ ><br>Timepoint: Assessment done at 2 time points: Time of enrollment and at the time of discharge
- Secondary Outcome Measures
Name Time Method Evaluation of <br/ ><br>-ventilation <br/ ><br>-oxygenation <br/ ><br>-hospitalization days <br/ ><br>-severity scores <br/ ><br>-laboratory parameters <br/ ><br>-weaning of vasopressors <br/ ><br>Safety would be assessed by monitoring for any adverse reactions due to ASV in patientTimepoint: Assessment done at 2 time points: Time of enrollment and at the time of discharge